4.3 Article

The activity regulation of the mitotic centromere-associated kinesin by Polo-like kinase 1

Journal

ONCOTARGET
Volume 6, Issue 9, Pages 6641-6655

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.2843

Keywords

MCAK/Plk1; phosphorylation; chromosome alignment; spindle assembly

Funding

  1. Deutsche Forschungsgemeinschaft [Yu 156/2-1]

Ask authors/readers for more resources

The mitotic centromere-associated kinesin (MCAK), a potent microtubule depolymerase, is involved in regulating microtubule dynamics. The activity and subcellular localization of MCAK are tightly regulated by key mitotic kinases, such as Polo-like kinase 1 (Plk1) by phosphorylating multiple residues in MCAK. Since Plk1 phosphorylates very often different residues of substrates at different stages, we have dissected individual phosphorylation of MCAK by Plk1 and characterized its function in more depth. We have recently shown that S621 in MCAK is the major phosphorylation site of Plk1, which is responsible for regulating MCAK's degradation by promoting the association of MCAK with APC/C-Cdc20. In the present study, we have addressed another two residues phosphorylated by Plk1, namely S632/S633 in the C-terminus of MCAK. Our data suggest that Plk1 phosphorylates S632/S633 and regulates its catalytic activity in mitosis. This phosphorylation is required for proper spindle assembly during early phases of mitosis. The subsequent dephosphorylation of S632/S633 might be necessary to timely align the chromosomes onto the metaphase plate. Therefore, our studies suggest new mechanisms by which Plk1 regulates MCAK: the degradation of MCAK is controlled by Plk1 phosphorylation on S621, whereas its activity is modulated by Plk1 phosphorylation on S632/S633 in mitosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Boosting the apoptotic response of high-grade serous ovarian cancers withCCNE1amplification to paclitaxelin vitroby targeting APC/C and the pro-survival protein MCL-1

Monika Raab, Nene F. Kobayashi, Sven Becker, Elisabeth Kurunci-Csacsko, Andrea Kraemer, Klaus Strebhardt, Mourad Sanhaji

INTERNATIONAL JOURNAL OF CANCER (2020)

Review Biochemistry & Molecular Biology

Caspase-8: The double-edged sword

Ranadip Mandal, Joan Compte Barron, Izabela Kostova, Sven Becker, Klaus Strebhardt

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)

Review Oncology

The role of caspase-8 in the tumor microenvironment of ovarian cancer

Izabela Kostova, Ranadip Mandal, Sven Becker, Klaus Strebhardt

Summary: Caspase-8, a key regulator in multiple signaling pathways, not only controls cell cycle and behavior but also immune response and cytokine production within the tumor microenvironment. Dysregulated expression of caspase-8 in ovarian cancer influences tumor aggressiveness and immune resistance, highlighting its potential as a therapeutic target for developing new treatment strategies against the complex tumor microenvironment.

CANCER AND METASTASIS REVIEWS (2021)

Review Cell Biology

Modelling the Functions of Polo-Like Kinases in Mice and Their Applications as Cancer Targets with a Special Focus on Ovarian Cancer

Monika Kressin, Daniela Fietz, Sven Becker, Klaus Strebhardt

Summary: Polo-like kinases (PLKs) are a group of highly conserved serine/threonine kinases that play crucial roles in tumorigenesis, particularly with the overexpression of PLK1 being associated with poor prognosis in different cancers. Current research is focusing on investigating the multiple functions of PLKs and their potential as cancer targets, with a specific emphasis on PLK1 and PLK4 inhibition in various cancer trials.

CELLS (2021)

Article Oncology

The Small-Molecule Inhibitor MRIA9 Reveals Novel Insights into the Cell Cycle Roles of SIK2 in Ovarian Cancer Cells

Monika Raab, Marcel Rak, Roberta Tesch, Khayal Gasimli, Sven Becker, Stefan Knapp, Klaus Strebhardt, Mourad Sanhaji

Summary: The study found that MRIA9 enhances the efficacy of paclitaxel in eliminating ovarian cancer cells and inhibits the activity of SIK2, leading to abnormal mitosis. Additionally, MRIA9 increases sensitivity to paclitaxel, suggesting selective targeting of SIK2 in ovarian cancer as a potential therapeutic strategy for overcoming paclitaxel resistance.

CANCERS (2021)

Article Medicine, General & Internal

Human placental mesenchymal stromal cells are ciliated and their ciliation is compromised in preeclampsia

Sophia Indira Romberg, Nina-Naomi Kreis, Alexandra Friemel, Susanne Roth, Alice Steglich Souto, Samira Catharina Hoock, Kyra Fischer, Thorsten Nowak, Christine Solbach, Frank Louwen, Andreas Ritter, Juping Yuan

Summary: This study found that the functionality of hCV-MSCs is dependent on primary cilia and that primary cilia are impaired in hCV-MSCs from preeclamptic placentas.

BMC MEDICINE (2022)

Article Biochemistry & Molecular Biology

A dimerization-dependent mechanism regulates enzymatic activation and nuclear entry of PLK1

Monika Raab, Yves Matthess, Christopher A. Raab, Niklas Gutfreund, Volker Doetsch, Sven Becker, Mourad Sanhaji, Klaus Strebhardt

Summary: PLK1 activation during the G2 phase is controlled by dimerization supported by Bora and dissociation triggered by Aurora-A phosphorylation, allowing timely entry into mitosis. Interfering with this dimer/monomer switch affects PLK1's nuclear shuttling and localization during the G2-M transition, suggesting potential for novel PLK1 inhibitors.

ONCOGENE (2022)

Article Oncology

Mitotic Centromere-Associated Kinesin (MCAK/KIF2C) Regulates Cell Migration and Invasion by Modulating Microtubule Dynamics and Focal Adhesion Turnover

Ha Hyung Moon, Nina-Naomi Kreis, Alexandra Friemel, Susanne Roth, Dorothea Schulte, Christine Solbach, Frank Louwen, Juping Yuan, Andreas Ritter

Summary: The microtubule cytoskeleton regulator MCAK plays a critical role in cell motility and migration by affecting the dynamics of actin-MT cytoskeleton and FA turnover, potentially promoting malignant progression and metastasis of tumor cells.

CANCERS (2021)

Review Oncology

Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer

Maximilian Fleischmann, Georgios Chatzikonstantinou, Emmanouil Fokas, Jorn Wichmann, Hans Christiansen, Klaus Strebhardt, Claus Roedel, Nikolaos Tselis, Franz Roedel

Summary: Despite advancements in screening and vaccination programs, uterine cervical cancer remains a leading cause of cancer-related mortality in women worldwide. New therapeutic approaches have not significantly improved treatment response and prognosis, highlighting the urgent need for robust molecular markers to predict therapy response and clinical outcome.

CANCERS (2021)

Review Oncology

Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells, Obesity and the Tumor Microenvironment of Breast Cancer

Andreas Ritter, Nina-Naomi Kreis, Samira Catharina Hoock, Christine Solbach, Frank Louwen, Juping Yuan

Summary: Adipose tissue-derived mesenchymal stromal/stem cells (ASCs/MSCs), especially in the obese state, play a critical role in the remodeling of the tumor microenvironment and promoting breast cancer progression. This review discusses the impact of obesity on ASCs/MSCs and their crosstalk with breast cancer cells, as well as the related molecular mechanisms and potential clinical significance. The roles of ASCs/MSCs in various aspects of breast cancer progression are highlighted, and targeting these cells may offer a new approach for effective breast cancer treatment.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Sequential Targeting of PLK1 and PARP1 Reverses the Resistance to PARP Inhibitors and Enhances Platin-Based Chemotherapy in BRCA-Deficient High-Grade Serous Ovarian Cancer with KRAS Amplification

Khayal Gasimli, Monika Raab, Morva Tahmasbi Rad, Elisabeth Kurunci-Csacsko, Sven Becker, Klaus Strebhardt, Mourad Sanhaji

Summary: This study found that amplification of KRAS may be the underlying cause of PARPi resistance in BRCA2-deficient high-grade serous ovarian cancer (HGSOC). Inhibition of PLK1 has shown to restore sensitivity to PARPi in KRAS-amplified HGSOC and enhance the cellular apoptotic response to carboplatin-based chemotherapy. These findings shed new light on the role of PLK1 in reversing PARPi resistance and offer a potential therapeutic strategy for ovarian cancer patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Editorial Material Oncology

Microtubule Dynamics and Cancer

Andreas Ritter, Nina-Naomi Kreis

CANCERS (2022)

Article Oncology

Cancer-educated mammary adipose tissue-derived stromal/stem cells in obesity and breast cancer: spatial regulation and function

Andreas Ritter, Nina-Naomi Kreis, Susanne Roth, Alexandra Friemel, Babek Kahn Safdar, Samira Catharina Hoock, Julia Maria Wildner, Roman Allert, Frank Louwen, Christine Solbach, Juping Yuan

Summary: This study reveals how obesity affects the phenotype of breast adipose tissue-derived mesenchymal stromal/stem cells (bASCs) and highlights the molecular changes inside breast cancer cells upon cell-cell interaction with these cancer-educated bASCs. These findings provide a new intervention strategy for breast cancer patients.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2023)

Article Oncology

Prognostic Impact of Caspase-8, CDK9 and Phospho-CDK9 (Thr 186) Expression in Patients with Uterine Cervical Cancer Treated with Definitive Chemoradiation and Brachytherapy

Maximilian Fleischmann, Ranadip Mandal, Izabela Kostova, Monika Raab, Mourad Sanhaji, Stephanie Hehlgans, Markus Diefenhardt, Claus Roedel, Emmanouil Fokas, Klaus Strebhardt, Franz Roedel

Summary: Elevated levels of caspase-8 and CDK9 are associated with improved outcomes in cervical cancer patients treated with primary platinum-based chemoradiation, while higher levels of phosphorylated CDK9 predict worse survival. Biomarker research can help improve treatment strategies for cervical cancer patients.

CANCERS (2022)

Correction Biochemistry & Molecular Biology

A dimerization-dependent mechanism regulates enzymatic activation and nuclear entry of PLK1 (vol 41, pg 372, 2022)

Monika Raab, Yves Matthess, Christopher A. Raab, Niklas Gutfreund, Volker Doetsch, Sven Becker, Mourad Sanhaji, Klaus Strebhardt

ONCOGENE (2023)

No Data Available